Accordingly, elevated levels of protective PUFAs might contribute to improved mitochondrial function (i.e., increased β-HAD activity and PPARα activation) to attenuate development of metabolic disease in PQQ-supplemented offspring. The gene discussed is PPARA; the disease is Other metabolic disease.